— Know what they know.
Not Investment Advice

IMTX NASDAQ

Immatics N.V.
1W: -3.3% 1M: -14.6% 3M: -19.2% YTD: -30.5% 1Y: -28.7% 3Y: -16.7% 5Y: -45.2%
$7.26
+0.11 (+1.54%)
 
Weekly Expected Move ±8.8%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $1.1B mcap · 128M float · 0.510% daily turnover · Short 33% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 1.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down 99.9%), Immatics N.V. would be worth roughly what it owes.
Total debt $16.2M against a stock market value of $1.09B.
Distance to default 10.11 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.0M (short-term plus half of long-term), stock volatility 57.4%; Altman Z'' 0.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$562M -19.3% ▼
5Y CAGR: +17.2%
Total Liabilities
$78M -35.5% ▼
5Y CAGR: -12.3%
Shareholders Equity
$484M -15.8% ▼
5Y CAGR: +35.9%
Cash & Investments
$469M -22.4% ▼
5Y CAGR: +15.1%
Total Debt
$16M -3.5% ▼
5Y CAGR: +20.4%
Net Debt
-$330M -49.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$133M$149M$218M$237M$346M
Short-Term Investments$12M$214M$207M$368M$123M
Cash & ST Investments$145M$362M$426M$604M$469M
Net Receivables$2M$1M$6M$7M$7M
Inventory$0$0$0$0$0
Other Current Assets$950K$14M$7M$6M$15M
Total Current Assets$152M$377M$449M$630M$504M
Property, Plant & Equip.$20M$26M$57M$64M$55M
Goodwill & Intangibles$1M$2M$2M$2M$2M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$636K$3M$2M$1M$2M
Total Non-Current Assets$22M$31M$61M$67M$58M
Total Assets$175M$408M$510M$696M$562M
— Liabilities —
Accounts Payable$3M$4M$8M$10M$340K
Short-Term Debt$0$0$0$0$3M
Deferred Revenue$50M$65M$100M$36M$16M
Other Current Liabilities$28M$18M$20M$5M$22M
Total Current Liabilities$95M$106M$157M$68M$43M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$48M$42K$116M$0$0
Total Non-Current Liabilities$55M$88M$128M$53M$35M
Total Liabilities$151M$195M$285M$121M$78M
— Equity —
Common Stock$629K$767K$847K$1M$1M
Retained Earnings-$538M-$500M-$597M-$590M-$786M
Accumulated OCI-$4M-$1M-$2M$1M-$9M
Total Stockholders Equity$24M$213M$225M$575M$484M
Total Liabilities & Equity$175M$408M$510M$696M$562M
— Key Metrics —
Total Debt$10M$15M$15M$16M$16M
Net Debt-$123M-$134M-$203M-$221M-$330M
Total Investments$12M$214M$207M$368M$123M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms